Visit COVID-19 resources

[Skip to Content]

Serum Eye Drops for the Treatment of Severe Ocular Surface Disease: Membership Consultation

2 June 2017

The Royal College of Ophthalmologists have, through a guideline development group (GDG) chaired by Miss Saaeha Rauz, produced a clinical guideline on Serum Eye Drops for the Treatment of Severe Ocular Surface Disease.

A draft version of this guideline has now been released for consultation (documents below) and the College would welcome any comments or observations on the content, format or recommendations.

[publication id=”16405″]

This is an opportunity for the membership of the college to contribute to and influence the form of the final guideline.

The purpose of this consultation is to obtain suggestions of additional sources of evidence which the GDG may wish to consider, or alternative interpretation of the evidence leading to a rephrasing or amendment of the recommendations.

We would be grateful if you could provide your comments by June 20th 2017.

Please return your comments or submit any queries concerning the guideline or the development process to Barny Foot (barny.foot@rcophth.ac.uk).